They evaluated the levels of anti-PGL-1 IgM antibody as well as IP-10, CCL4 and CRP in blood collected from leprosy patients and observed that combined detection of these biomarkers significantly improved the diagnostic potential, particularly for PB leprosy in all studied regions. This evidence concerns the gene CCL4 and leprosy.